Home / Advanced Wound Care / Professionals / Clinical Perfomance

Geistlich Derma-Gide®

Evidence Supporting
Geistlich Derma-Gide®

Clinically Proven | Cost Effective

When it comes to the safety and quality of its products…Geistlich does not compromise.

Decades of experience with biomaterials and pioneering work achieved are documented in meaningful scientific evidence. Here is a look at Geistlich’s ever growing scientific and clinical body of evidence for Geistlich Derma-Gide® published in world-renowned and prestigious global journals. Watch or read for yourself . . .

Armstrong, David G. et al. “Use of a Purified Reconstituted Bilayer Matrix (PRBM) in the Management of Chronic Diabetic Foot Ulcers Improves Patient Outcomes vs Standard of Care – Results of a Prospective Randomized Controlled Multi-Center Clinical Trial”. International Wound Journal, 2022; 1-13. Wileyhttps://doi.org/10.1111/iwj.13715


Armstrong, David G. et al. “Functional Properties Of A Purified Reconstituted Bilayer Matrix Design Support Natural Wound Healing Activities”. Plastic and Reconstructive Surgery–Global Open, vol 9, no. 5, 2021, p. E3596. Ovid Technologies (Wolters Kluwer Health)https://doi.org/10.1097/gox.0000000000003596

Geistlich Derma-Gide® Mode of Action


Armstrong, David G. “An Observational Pilot Study Using A Purified Reconstituted Bilayer Matrix To Treat Non-Healing Diabetic Foot Ulcers”. International Wound Journal, vol 17, no. 4, 2020, pp. 966-973. Wileyhttps://doi.org/10.1111/iwj.13353

SAWC Fall 2019 Innovation Spotlight: Charles Zelen presents Geistlich Derma-Gide®



CAUTION: This product is only available in the U.S.A. Federal (U.S.A.) law restricts these devices to sale by or on the order of a physician.

Alternative location found

You current location seems to be: Unknown

Would you like to proceed to https://www.geistlich-pharma.com ?